THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Whistle-blowers' spotlight falls on drug companies

US rules allowing big payouts weigh on life-sciences industry

By Ross Kerber
Globe Staff / April 22, 2005

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Former federal prosecutors report a sharply rising rate of private lawsuits filed in Boston by people urging the government to bring fraud charges against their employers, especially drug companies. (Full article: 1124 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass